Drawing for VYGORIS

USPTO serial 79231304

VYGORIS

Reviewed by CopyMark Law Group

Reg. 5815746Status 709
Filing date
Status date
Registration date
Jul 30, 2019
Examiner
HAN, DAWN L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with VYGORIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medicinal, pharmaceutical, and veterinary preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; radioactive substances for medical purposes; dietary supplements for humans and animals; pharmaceutical preparations and medical substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; medicines and pharmaceuticals for use in oncology; pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, available on prescription only; pharmaceutical preparations available on prescription only, namely, cytostatics; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in urology; and pharmaceutical products for the prevention and treatment of cancerSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 13, 2026C71TCANCELLED SECTION 71—
Jul 30, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 15, 2024CHLDCHANGE OF OWNER RECEIVED FROM IB—
Nov 5, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 6, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 16, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 16, 2019FIMPFINAL DISPOSITION PROCESSED—
Oct 30, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 30, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 20, 2019ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jan 10, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Dec 11, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 11, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 8, 2018GPNXNOTIFICATION PROCESSED BY IB—
Nov 21, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 21, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 21, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 1, 2018ALIEASSIGNED TO LIE—
Oct 18, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 26, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 26, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 26, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 9, 2018RFNPREFUSAL PROCESSED BY IB—
May 18, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 18, 2018RFRRREFUSAL PROCESSED BY MPU—
May 17, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 16, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
May 8, 2018DOCKASSIGNED TO EXAMINER—
May 8, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 3, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance